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The female reproductive tract harbors distinct microbial communities, as in the vagina,
cervical canal, uterus, and fallopian tubes. The nature of the vaginal microbiota is
well-known; in contrast, the upper reproductive tract remains largely unexplored.
Alteration in the uterine microbiota, which is dependent on the nutrients and hormones
available to the uterus, is likely to play an important role in uterine-related diseases such
as hysteromyoma, adenomyosis, and endometriosis. Uterine mucosa is an important
tissue barrier whose main function is to offer protection against pathogens and other
toxic factors, while maintaining a symbiotic relationship with commensal microbes. These
characteristics are shared by all the mucosal tissues; however, the uterine mucosa is
unique since it changes cyclically during the menstrual cycle as well as pregnancy.
The immune system, besides its role in the defense process, plays crucial roles in
reproduction as it ensures local immune tolerance to fetal/paternal antigens, trophoblast
invasion, and vascular remodeling. The human endometrium contains a conspicuous
number of immune cells, mainly Natural Killers (NK) cells, which are phenotypically
distinct from peripheral cytotoxic NK, cells and macrophages. The endometrium also
contains few lymphoid aggregates comprising B cell and CD8+ T cells. The number
and the phenotype of these cells change during the menstrual cycle. It has become
evident in recent years that the immune cell phenotype and function can be influenced
by microbiota. Immune cells can sense the presence of microbes through their pattern
recognition receptors, setting up host-microbe interaction. The microbiota exerts an
appropriately controlled defense mechanism by competing for nutrients and mucosal
space with pathogens. It has recently been considered that uterus is a non-sterile
compartment since it seems to possess its ownmicrobiota. There has been an increasing
interest in characterizing the nature of microbial colonization within the uterus and
its apparent impact on fertility and pregnancy. This review will examine the potential
relationship between the uterine microbiota and the immune cells present in the
local environment.
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INTRODUCTION
Mucosal barriers are the first line of immune defense designed
to induce protection against noxious environmental agents
including pathogens, and simultaneously allow symbiosis with
commensal microbes (1). The largest number of commensals
are segregated along the gastrointestinal tract; this segregation
is achieved by the combined action of epithelial cells, mucus,
IgA, anti-microbial peptides and immune cells (2, 3). One major
benefit from the homeostatic relationship between the host and
the microbiota is the resistance to pathogen colonization (4).
It has been demonstrated that the microbiota is able to
influence the function of the host immune system, which keeps
a symbiotic relationship with the microbiota. The ability of
microbes to modulate the immunological response, both locally
and systemically, requires sensing of microbes, followed by
complex dialogue between innate and adaptive components of
the immune system (2).
The uterine mucosal immune system is quite unique
compared to other mucosal surfaces since it has to adapt to
menstruation in response to hormonal stimuli (1). In addition
to binding with the pathogens, the uterine immunity has evolved
to tolerate the semi-allogeneic fetus, thus, playing a fundamental
role in implantation and pregnancy (5).
The uterine microenvironment, for a long time, has been
considered to be a sterile compartment, although the likely
existence of commensal colonization within the uterus was
always debated. Only recently, thanks to the discovery of the
16S rRNA in the uterine compartment, it has been possible
to demonstrate and characterize the presence of commensal
bacteria in the uterus. This review will focus on the immune
system that characterizes the endometrium, the microbiota
present in the uterine microenvironment, and their mutual
homeostatic relationship.
ANATOMY OF THE UTERUS
The female reproductive tract comprises the fallopian tubes, the
uterus, and the vagina.
The uterus is the organ involved in the gestation; it has
the function of accepting the fertilized egg and allowing its
development. The uterus is an unequal organ, which at the top
receives the outlet of the uterine tubes and at the bottom opens
into the vaginal cavity (6–8).
The uterus, a pear-shaped viscus, can be divided into a fundus,
body, and cervix. During pregnancy, it houses and supports
the developing embryo and fetus. It is composed of a thick,
muscular myometrium (covered by serosa and/or adventitia) and
a spongy mucosal layer, the endometrium. The cervix is the
inferior portion of the uterus, which protrudes into the vagina.
The lumen (canal) of the cervix is continuous with the lumen
of the uterus (superiorly) and the vaginal canal (inferiorly). It is
divided into two main parts: the endocervix is the inner part of
the cervix lining the canal leading into the uterus, whereas the
ectocervix is the outer part of the cervix. It is rounded and lip-
like and sticks out into the vagina. The endocervical canal is the
passage from inside the uterus to the vagina (6–8). The superior
surface of the uterus is convex and directed forward. The anterior
surface is flat and looks downward and forward, resting on the
bladder. Its peritoneal covering is reflected at the level of isthmus
to the upper aspect of the bladder, creating the vesico-uterine
pouch. The posterior surface of the uterus is convex and lies in
relation to the pelvic colon and rectum. The peritoneum of the
posterior wall covers the body and upper cervix, and then extends
over the posterior fornix of the vagina to the rectum, to form
the recto-uterine pouch or cul-de-sac of Douglas. The cervix
is directed downward and backward to rest again the posterior
wall. Only the upper half of its posterior surface is covered by
peritoneum. The external side of the cervix lies at about the level
of the upper border of the symphysis pubis in the plane of ischial
spine (6–8).
The uterine wall is constituted by mucous or endometrium
tunic, muscular or myometrium tunic, and serous tunic,
where it is referred to as perimetry. A connective tissue
constitutes the perimeter that surrounds the uterus, below
the peritoneum, extending into the base of the broad
ligament (6–8).
The endometrium, composed of an epithelial lamina propria,
with its superficial functional and deep basal layers, undergoes
hormonally modulated cyclic changes during the menstrual
cycle. The three cyclic stages of the endometrium are the:
follicular (proliferative) phase, luteal (secretory) phase, and the
menstrual phase. The basal layer, which remains intact during
menstruation, is served by short straight arteries and is occupied
by the base of the uterine glands. The functional layer, served by
the helicine (coiled) arteries, undergoes hormonally modulated
cyclic changes. Follicle-stimulating hormone (FSH) facilitates
the proliferative phase (follicular phase), characterized by
thickening of the endometrium and the renewal of the connective
tissue, glandular structures and blood vessels (helicine arteries)
subsequent to the menstrual phase. Luteinizing hormone (LH)
facilitates the secretory phase (luteal phase), characterized
by the further thickening of the endometrium, coiling of
the endometrial glands, accumulation of glandular secretions,
and further coiling and lengthening of the helicine arteries.
Decreased levels of LH and progesterone are responsible for
the menstrual phase, which begins with long-term, intermittent
vasoconstriction of the helicine arteries, with subsequent necrosis
of the vessel walls as well as of the endometrial tissue of
the functional layer. It should be noted that the basal layer
is unaffected because it is supplied by the straight arteries.
During relaxation (between episodes of vasoconstriction), the
helicine arteries rupture, and the rapid blood flow dislodges the
blood-filled necrotic functional layer, which becomes sloughed
as the hemorrhagic discharge, so that only the basal layer of the
endometrium remains as the lining of the uterus (7, 9).
CHARACTERISTICS OF THE MUCOSA OF
THE FEMALE REPRODUCTIVE TRACT
As mentioned earlier, the female reproductive tract comprises
the fallopian tubes, the uterus, and the vagina. The mucosa of
the female reproductive tract differs between the upper and the
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lower tracts. The upper female reproductive tract that includes
the uterine tubes, uterus and the endocervix, and is covered by a
single-layered columnar epithelium. The lower reproductive tract
includes the ectocervix and vagina, and is lined with a single layer
of stratified, squamous, non-keratinized epithelium, which forms
a more protective barrier than the columnar epithelium (10, 11).
Anti-microbial molecules, produced in the mucosa of
the female reproductive tract, are significantly influenced
by estrogen, which acts differently in the upper and lower
reproductive tracts. High levels of estrogen, a characteristic
of the pre-ovulatory period, increase the production of some
anti-microbial peptides, such as secretory leukocyte peptidase
inhibitor (SLPI), β-defensin 1-2 (HBD 1-2), and elafin from
the endometrial epithelium (12). On the other hand, estrogen
suppresses the LPS- and poly (I:C)-induced secretion of
pro-inflammatory cytokines, including TNF-α, macrophage
inflammatory protein 3α (MIP3α, CCL20), IL-1β, IL-6, and
IL-8 from uterine epithelial cells. IgG levels in the uterine
cavity peak in the periovulatory period. In contrast, the lower
reproductive tract, including the cervix and the vagina, maintains
a low level of IgA, IgG, and lactoferrin and decreased secretions
of β-defensin 2, elafin, SLPI, and α-defensin1-3 (HNP1-3).
Furthermore, concentrations of IL-6 and IL-8 in the vagina
are decreased in the period of highest estrogen concentration
(12). This decreased immunity in the lower genital tract may
contribute to enhanced sperm survival in the periovulation
period. In addition, the estrogen rise in the periovulatory period
increases the levels of anti-microbial peptides and decreases pro-
inflammatory cytokines in the upper genital tract, which prevents
ascending infections by vaginal pathogens and provides favorable
conditions for the transit of sperm and embryos.
UTERINE MICROBIOTA
The endometrium of healthy women, for a long time, has
been considered as a sterile environment. However, the use
of next-generation sequencing techniques has enhanced our
understanding of the complexity and number of microbiota
that inhabit human mucosal surfaces. Recently, it has been
demonstrated that the sites of the body that were previously
thought to be devoid of bacteria, such as the lungs (13), bladder
(14), placenta and endometrium (15, 16), are in fact colonized
by low-abundance and unique microbiota (17), each tissue and
microenvironment hosting unique microbial communities (18).
The first study that provided information about uterine
colonization by bacteria used endometrium of 78 patients after
hysterectomy. The authors were able to show the presence
of pathogens in culture in 6% of these patients. They also
demonstrated the presence of carcinoma of the cervix but no
other pathologic condition may predispose to microbial invasion
of the uterine cavity (19).
The presence of microbes in the uterine cavity was later
demonstrated by Moller et al. (20). A prospective study involved
the uteri from 99 women admitted for hysterectomy for
persistent irregular vaginal bleeding and fibromyomas. The
uteri were opened under sterile conditions immediately after
hysterectomy and samples were obtained from the isthmus and
fundus of the uterine cavity for microbiological examination.
In nearly a quarter of all the patients, the uterine cavity was
colonized with potentially pathogenic organisms, harboring one
or more microorganisms in the uterus, most notably Gardnerella
vaginalis, Enterobacter, and Streptococcus agalactiae. Mitchell
et al. recently evaluated the presence of vaginal bacterial species
by species-specific quantitative PCR in excised uteri obtained
from 58 patients (21). They detected mostly the presence of
Liners, Prevotella spp. and L crispatus with the median quantities
of bacteria 2–4 log10 lower those that present in the vagina.
Recent studies via next generation sequencing have yielded
important information about the presence of many genera of
bacteria in the non-pregnant human uterus.
An interesting study by Moreno et al. analyzed endometrial
fluid and vaginal aspirates obtained from 13 fertile women in pre-
receptive and receptive phases within the same menstrual cycle
(22). They also investigated endometrial fluid collected at pre-
receptive and receptive phases from 22 fertile women to study
the hormonal regulation of the endometrial microbiota. Genomic
DNA was sequenced for the 16S ribosomal RNA (rRNA)
gene. The data demonstrated that the presence of endometrial
microbiota was not hormonally regulated during the acquisition
of endometrial receptivity. Furthermore, the presence of a non-
lactobacillus-dominated microbiota in a receptive endometrium
was associated with significant decrease in implantation and
pregnancy outcome.
Chen et al. analyzed the microbiota present in the lower
vagina, posterior fornix, cervical mucus, endometrium, fallopian
tubes, and peritoneal fluid obtained from the pouch of Douglas
in women being operated for benign and non-infectious
conditions (23). A significant fraction of the non-pregnant
uterine microbiota comprises not only Lactobacillus spp., which
is similar to the vaginal mucosa, but also a variety of bacteria that
grow in mildly alkaline conditions (23). Although characterized
by a lower bacterial biomass, endometrial samples have a higher
bacterial diversity compared to the vaginal microbiota (24).
The metabolic profiles of the vagino-uterine microbiota change
throughout the menstrual cycle. The functions of these microbes
in uterine mucosal immune homeostasis in non-pregnant and
pregnant states remain to be ascertained (1).
Few studies have attempted to investigate the correlation
between bacterial colonization and pregnancy outcome, by
culturing catheter tips used for embryo transfer during in vitro
fertilization. The results were not conclusive, probably due to the
fact that in culture, the aerobic species dominate, in addition to
potential contamination through the cervicovaginal canal (25).
IMMUNE CELLS RESIDING IN THE
FEMALE REPRODUCTIVE TRACT
There are conflicting reports in terms of the leukocyte population
in the female reproductive tract. This discrepancy arises from
the differences in the sampling phase during the menstrual cycle,
sample size, analytical methods, and antibodies used to identify
immune cells (10). However, it is clear that the number of
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leukocytes per gram of endometrial tissue is greater than that of
other reproductive tissues, including fallopian tube, endocervix,
ectocervix, and vagina (10).
Immune cells residing in the reproductive tract are required
to play paradoxical roles since they maintain immunity against
pathogens and also establish immune tolerance for sperm and
embryo/fetus in the upper tract (10). Natural killer (NK) cells
and regulatory T (Treg) cells are extremely important in decidual
angiogenesis, trophoblast migration, and immune tolerance
during pregnancy (10). Dysregulation of endometrial/decidual
immune cells is strongly associated with infertility, miscarriage,
and other obstetric complications (10).
The leukocytes in the female reproductive tract are distributed
in either an aggregated or a dispersed form in the epithelial
layer, lamina propria, and stroma (10). Although differentially
distributed in each organ of the female reproductive tract, the
predominant immune cells are T cells, macrophages/dendritic
cells, NK cells, neutrophils, and mast cells (10). B cells are rare
in the female reproductive tract (10) (Figures 1, 2).
Sex steroid hormones significantly influence these cells
although they lack receptors for estrogen and progesterone
(12, 26). As in the peripheral blood, leukocytes in the female
reproductive tract also fluctuate in number cyclically through the
menstrual cycle, probably as an indirect response to estrogenic
and progesterone (12). The importance of these uterine immune
cells is being discussed below.
Innate Lymphoid Cells (ILCs)
Innate lymphoid cells (ILCs) are divided into three primary
groups based on their phenotype and functions: type 1 (ILC1),
type 2 (ILC2), and type 3 (ILC3) (27). Recently, the classification
of ILCs has been be expanded to five subsets to reflect their
distinct developmental pathways: NK cells, ILC1, ILC2, ILC3,
and lymphoid tissue inducer (LTi) cells (28). It has been shown
that only ILC3s are present in human endometrium and decidua,
whereas all three groups of ILCs are present in the mouse
uterus (29). The differences in the distribution of ILCs between
human and mouse may reflect the dramatic changes that the
mucosa undergoes in the human menstrual cycle with cyclical
degeneration and renewal (29).
ILC1 include the prototypical NK cells and non-
cytotoxic IFN-γ producing ILC1, characterized by
expression of the transcription factor T-bet (27). ILC1s
(Lin-CD56+CD127−CD117−RORγt−cells) are found in human
non-pregnant endometrium, are further distinguished on the
basis of their expression of NKp44 and CD103. CD103+NKp44−
cells are the principal source of IFN-γ (30), whereas, as previously
described for tonsillar ILC1s (31), CD103+ expression facilitate
the molecular communication between lymphocytes and
epithelial cells (32), suggesting an epithelial association of such
cells in the uterus.
ILC2 function through the release of helper T cell type 2 (Th2)
cytokines such as IL-5 and IL-13 (33) and participate in immune
responses, for example, against parasitic infection (34) and allergy
(35); they also serve as systemic regulators of homeostasis (36).
Most of the information about these cells are based on mouse
models. For instance, murine uterine ILC2 are able to express
FIGURE 1 | (A) Endometrium of human uterus. Immunohistochemical analysis
of human endometrium on frozen section stained with CK7 monoclonal
antibody (Dako) of uterus in proliferative phase. Bound antibody was revealed
using the LSAB+ HRP kit and 3,3′-diaminobenzidine tetrahydrochloride (DAB)
as chromogen. The sections were counterstained with hematoxylin.
Monostratified columnar epithelium and the basal layer, which remains intact
during menstruation, is occupied by the base of the uterine glands. Original
magnifications 200×. (B) Immunological components of uterine mucosa. The
endometrium is populated by a range of immune cells, such as mast cells,
Macrophages (M8), Neutrophils (Neu), Dendritic cells (DC), T and B cells. The
presence of lymphoid aggregates in the endometrial tissue suggests that this
is an active site for cell-mediated immunity. Lymphoid aggregates found
beneath the endometrium are composed of B cells in the inner core,
surrounded by CD8+ CD4− T cells and an outer layer of macrophages.
Scattered CD56+ natural killer (NK) cells and CD4+ T cells can also be found
in between lymphoid aggregates.
the estrogen receptor α (37) and their percentage is increased in
response to in vitro stimulation with 17β-estradiol.
ILC3 are divided into two main groups: LTi cells and non-LTi
ILC3, referred to hereafter as ILC3 (27). For the first time, ILC3
have been described in the human non-pregnant endometrium.
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FIGURE 2 | The immune cells (Left) and microbiota (Right) within the female genital tract and semen. On the left side are the percentage with (respect to total CD45
positive cells) of T Lymphocytes (T), NK cells (NKs), Granulocytes (G), Macrophages (M), and B Lymphocytes (B) in Endometrium, Endocervix, Ectocervix, Vagina and
semen. On the right side, is shown the median relative abundance of microbial genera. ++++/+ represent the relative abundance amount of microorganisms and
immune cells in different areas.
They represent a distinct subset of NK precursor-like cells that
present ILC-associated markers such as CD127 and CD161 (38).
The expression of the RORC and IL-22 genes that characterize
an ILC3 phenotype, was also demonstrated (38). Subsequently,
other studies confirmed the presence of ILC3 in the human
endometrium (37, 38). These cells are divided into two main
subsets: NCR− (human NKp44−; mouse NKp46−) and NCR+
(human NKp44+; mouse NKp46+) ILC3s (7), with the NCR−
ILC3 being the dominant population inmice and the NCR+ ILC3
in humans. Apart from the NK cells, the potential role of other
ILCs in the uterus is not fully known.
Uterine NK Cells
Uterine NK cells have also been called as Large Granular
Lymphocytes (LGL), endometrial granulocytes, K cells,
endometrial Granulated Lymphocytes (eGL), and decidual
Granulated Lymphocytes (dGL) (39). The major phenotype
of endometrial NK cells is CD3− CD56bright CD16−, which
distinguishes this cell subset from CD3− CD56dim CD16+
NK cells in the peripheral blood (10, 39). It is possible
that peripheral blood CD56bright NK cells home in to the uterus
where they undergo tissue-specific differentiation. NK cells in the
endometrium significantly expand in the late secretory phase and
further increase their number during early pregnancy (10, 26).
In the proliferative phase, only a few NK cells are scattered
throughout the stroma of the functional layer. However, they
show a dramatic increase in their number after ovulation and
continue to increase until a few days prior to menstruation.
In the late secretory phase, the NK cells number surges up
to 40% of the total cells in the stromal compartment and
∼70% of endometrial leukocytes (10, 39). NK cells, particularly,
surround both the arteries and glands of the endometrium.
Since there are few NK cells in the endometrium in the
menstrual and proliferative phases, an association between
falling progesterone and apoptosis of uterine NK cells has been
suggested. Considering that the NK cells and other leukocytes in
the uterus do not express progesterone receptors, progesterone
might exert its effects indirectly via cytokines or other soluble
factors produced by stromal cells. Stromal cells strongly express
both estrogen receptors (ERs) and progesterone receptors (PRs)
(39). Carlino et al. demonstrated that uterine stromal cells from
fertile or menopausal women were able to release chemerin,
and exposure of uterine stromal cells to progesterone and 17β-
estradiol resulted in enhanced chemerin release, supporting
peripheral blood NK cell migration through uterine stromal
cells (40).
Macrophages
CD68+ macrophages are detected in all phases of the menstrual
cycle (41). These cells also express specific markers such as
CD71, CD69, and CD54 (42). These macrophages are scattered
throughout the endometrium and are found especially around
the glands (43). Tissue macrophages acquire distinct functional
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phenotypes, ranging between pro-inflammatory (M1) and anti-
inflammatory pro-wound healing (M2) phenotype, in response
to environmental cues (44). Studies using human tissues have
revealed a progressive increase in the number of macrophages
during the secretory phase of the cycle that peaks during
menstruation, representing up to ∼15% of the leukocyte
population (45). CD68+ macrophages are abundant in the
human endometrium during tissue breakdown and repair, and
probably have a role in tissue clearance and tissue remodeling
associated with menstruation (46). Macrophages within the
endometrium have been suggested to have an important role
in fertility and induction of a pro-inflammatory cytokine
production (42). There is a significant increase in themacrophage
number in the secretory phase, especially prior to menses,
and this increase is particularly notable at the implantation
site (39, 47).
Neutrophils
Neutrophils, the most abundant leukocytes in the human
immune system, comprise about ∼10% of CD45+ cells in the
cervix, with a greater presence in the ectocervix (11). Neutrophils
have been identified in endometrial tissue by their morphology,
by immunolocalization of the neutrophil-specific protease,
elastase; in terms of surface markers, they have been defined as
CD11b bright, CD66b+, and CD16+ (48). During most of the
cycle, neutrophils are barely detectable in normal endometrium,
but the numbers rise dramatically perimenstrually, making upto
6–15% of the total cell number in the tissue (41).
IFN-γ has also been detected in intra-epithelial neutrophils
in human endometrium (48). In fact, neutrophils isolated from
normal donors produce IFN-γ in response to stimulation with
LPS, IL-12, and TNF-α. IFN-γ has a role in macrophage
activation (49), suggesting at least one potential interaction
between adjacent leukocytes during menstruation.
Mast Cells
Mast cells are present in the endometrium throughout the
menstrual cycle. They are detected by immunostaining for the
two-mast cell-specific serine proteinases, tryptase, and chymase,
and the extracellular relocation of the enzymes is indicative of
their activation state (41).
Endometrial mast cell activation corresponds closely to the
phases of tissue edema and is most marked prior to menstruation
(50). As mentioned above, mast cells fall into two well-known
phenotypic subtypes. Mucosal mast cells are positive for tryptase
but not chymase, whereas connective tissue mast cells contain
both enzymes. Both of these subtypes have been detected in
endometrium, with regional differences. Those in the basalis
region express both enzymes whereas those in the functionalis
are positive only for tryptase (50). While it is the functionalis
that is shed during menstruation, there is considerable tissue
destruction at the basalis functionalis interface, and it is likely
that both enzymes contribute to menstruation. Tryptase, and to a
lesser extent, chymase, can play an important role in establishing
a cascade of matrix metalloproteinase (MMP) activation and
this could represent a critical function for these cells in
the menstruation. Mast cells also produce histamine, heparin,
arachidonate products and a variety of pleiotropic cytokines and
growth factors, all of which have marked effects on endothelial
cell function and local induction of edema (51).
Dendritic Cells
Dendritic cells (DCs) are a heterogeneous and dynamic
population of leukocytes; they are the most potent antigen
capturing (immature DCs) and antigen presenting (mature DCs)
cells. They are highly involved in the stimulation and modulation
of the immune response within mucosal surfaces (52). In the
basal layer of the endometrium, the density of endometrial
CD1a+ immature DCs is significantly higher than that of CD83+
matureDCs throughout themenstrual cycle, whereas the number
of CD83+ mature DCs remain relatively constant (39, 53). The
number of CD1a+ immature DCs is likely to be indirectly
regulated by steroid hormones (53). The density of CD83+
DCs was significantly greater in the basal layer compared with
the functional layer during both the proliferative and secretory
phases, whereas for CD1a+ DCs, the greater density in the basal
layer was only observed in the secretory phase (53). Cyclical
changes in DC populations during the normal menstrual cycle
may be important for local regulatory mechanisms relevant
to menstruation and implantation. Alterations in this normal
profile may contribute to menstrual disturbances and fertility.
Lymphocytes
CD3+ T cells are a minor population in the endometrium,
comprising only ∼1–2% of the total lymphomyeloid cells (45).
These T cells are distributed at three different sites of the
endometrium: aggregated in the basal lymphoid, and scattered
in the stroma, and in the epithelial sites (41). In contrast to CD3+
T cells in peripheral blood, endometrial CD3+ T cells consist of a
larger proportion of CD8+ cells (66%) and smaller proportion of
CD4+ cells (33%) (41). Cytolytic activity of endometrial CD8+ T
cells is maintained during the proliferative phase, but this activity
weakens in the secretory phase without any drop in the CD8+ cell
number (12, 41). This suppression of CD8+ cytolytic activity has
been observed only in the fallopian tubes and endometrium, but
not in the cervix and vagina (12). CD45RA+ T cells were found
throughout the cycle, but their numbers are very low (41).
Hormonal changes may be drivers for Treg changes. In
particular, estrogen has been shown to induce expansion of
Foxp3+ Treg cells (54, 55), including in the pregnant uterus (56),
which is essential for promoting immune tolerance toward the
fetus. Activation of Treg is needed for a successful pregnancy,
while suppression of Treg was associated with pregnancy
failure (56).
Gamma/delta (γδ) T Cells
Two types of T cells, αβ T cells and γδ T cells are present in
vertebrates and are defined by surface expression of either the
αβ or the γδ TCR complex. Thymus is the origin tissue of both
these subsets but there are several key differences between αβ
and γδ T cells: (i) αβ T cells are primarily localized in secondary
lymphoid organs, whereas γδT cells are predominant at epithelial
surfaces; (ii) αβ T cells recognize peptide ligands in the context of
MHC class I and class II molecules, whereas γδ T cells do not
recognize peptides in an MHC-restricted manner but recognize
and respond to a broad range of antigens, including heat shock
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proteins, and lipids; and (iii) the role of αβ T cells in immune
response is well-defined whereas that of γδ T cell are not yet fully
characterized (57).
Haller et al. analyzed the presence of γδ-positive cells in
non-pregnant endometrium, and in first trimester and third
trimester basal decidua. They did not observe any substantial
differences in the number of γδ T cells in first and third trimester
basal decidua compared with the non-pregnant endometrium.
γδ T cells were occasionally found scattered throughout the
endometrial/decidual stroma and showed no clear distribution
pattern, nor was there any obvious relation to the pregnancy
in the first or third trimester (58). Although Heyborn et al.
showed that γδ T cells were significantly enriched at the feto-
maternal interface, compared to the periphery or the non-
pregnant uterus (59), the role of these lymphocytes in pregnancy
is not yet fully understood. Hill et al. observed an increased
number of TcRγδ-positive cells in spontaneous miscarriages
endometrium compared to normal pregnancies (60). Vassiliadou
and Bulmer showed that γδ-T cells were present in both
normal pregnancy and spontaneous pregnancy loss, often located
adjacent to endometrial glands (61). These cells formed a very
small proportion of T cells in both groups and there was no
difference in their numbers and proportions between normal and
pathological tissues.
ENDOMETRIAL LYMPHOID AGGREGATES
Endometrial lymphoid aggregates comprise a CD19+ B cell
core, surrounding T cells, and an outer halo of macrophages
in the stratum basalis (12, 39). These lymphocyte aggregates
vary in size with the phase of the menstrual cycle, becoming
larger in the secretory phase (3,000∼4,000 cells) than the
proliferative phase (300∼400 cells) (12). To form lymphoid
aggregates, immune cell trafficking to the nucleation sites is
likely to be the principle mechanism, rather than in situ
proliferation of precursor cells (62). Recruited immune cells from
the circulation are likely to undergo tissue-specific differentiation
in the local microenvironment, which confers new characteristics
on these tissue-specific cells that are distinct from their original
properties (39, 63).
CYCLIC FLUCTUATIONS OF
ENDOMETRIAL LEUKOCYTES
Endometrial leukocytes exhibit profound cyclic fluctuations
between the follicular and luteal phases of the menstrual cycle
(10). The mean number of CD45+ cells in the endometrium
remains low from the early follicular phase to the early secretory
phase, but increases considerably (about 5-fold) during the
secretory phase (64). The major population of CD45+ leukocytes
in the late secretory phase is NK cells comprising ∼80% of
CD45+ cells, while CD3+ T cells decrease to <10% (64).
Even though the percentage of CD3+ T cells is lower in the
late secretory phase, the absolute number of T cells remained
unchanged during the menstrual cycle. Comparing the late
proliferative phase with the late secretory phase, the proportion
of CD3+ CD8+ T cells decreases significantly from 63 to 54% (64)
(Figures 2, 3).
The number of CD3− CD56+ NK cells significantly increases
in the late secretory phase compared with other phases (64).
The cytotoxicity of endometrial NK cells is high, comparable to
peripheral NK cells in the late proliferative phase (65). Similarly,
the expression of the activation markers, CD69 and HLA-DR,
is increased on NK cells in the proliferative phase (66). These
characteristics of NK cells are likely to contribute to protective
immunity against microbial infections.
During the menstrual cycle, neutrophils and eosinophils
remain at a very low number in the endometrium, but their
numbers profoundly increase in the premenstrual period, up to
15% and 5% of endometrial cells, respectively (41, 45).
CD68+ macrophages were found throughout the cycle and
significantly increased from the proliferative phase to the
secretory phase (67). The density of endometrial CD1a+ DCs, but
not CD83+ DCs, in the basal layer gradually increased through
the menstrual cycle, showing a nadir at the proliferative phase
and reaching its peak in the menstrual phase (53). Only in the
secretory phase was the density of CD1a+ DCs greater in the
basal layer than in the functional layer. Endometrial CD83+ DCs
showed greater density in the basal layer than in the functional
layer throughout the menstrual cycle (53).
ROLE OF CERVICAL MUCUS IN
BACTERIAL UTERINE COLONIZATION
The portal between the uterus and the vagina is represented by
the cervix, which functions as an entrance to the endometrial
cavities. Cervix contains several hundred crypts (glands) lined
by cells which, under hormonal and neural influence, produce
mucus, composed mostly of water (95–99%) and a complex
mixture of organic components, inorganic ions, enzymes,
mucins, and a high concentration of cytokines, anti-microbial
peptides, immunoglobulins, and MMPs to protect the uterus
against bacterial colonization (68, 69). Mucus released into the
cervical canal moves into the vagina, where it acts as pathogen
traps. It is an important protective barrier, preventing the
ascendance of microorganisms into the uterus cavity; on the
other hand, it is essential for the migration of spermatozoa. It has
been shown that the hydration of the mucus and its glycosylation
state play a pivotal role in both these processes (70, 71). Mucins
in the cervix are known to change conformation during the
menstrual cycle due to pH; these variations possibly allow passage
of bacteria from vagina (72). However, bacteria from the lower
female reproductive tract are able to cross. Hansen et al. have
shown that the cervical mucus plug only inhibits (and does not
completely block) the passage of Ureaplasma parvum during its
ascendance from the vagina through the cervical canal (17, 73).
ROLE OF SEMEN IN BACTERIAL UTERINE
COLONIZATION
Besides all the putative bacterial transmission routes between
uterine microbiota and distal sites such as hematogenous spread
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FIGURE 3 | Uterine immune stages during menstruation cycle. During the normal menstrual cycle, the human endometrium is exposed to cyclical fluctuations of sex
hormones. The repetitive cycles of proliferation, differentiation, decidualization, and shedding of this tissue during mensuration and the steroid hormones per se cause
profound changes in the immune cells’ population. The estrogen-dominant proliferative phase is characterized by the regeneration of the functional layer of the
endometrium. In the progesterone driven secretory phase, the endometrium undergoes a number of changes in preparation for implantation of the embryo. The
immune cells that undergo greater number variations in the secretory phase are the NKs and macrophages. The microbiota, on the other hand, does not undergo
large variations during different phases of the menstrual cycle. Sphingobium sp., Propionibacterium acnes, and Pseudomonas sp. are differentially enriched during the
proliferative and secretory phases; P. acnes is more abundant in the secretory phase and has previously been identified in the placenta and cultured from follicular
fluid. Functionally, the proliferative phase, compared to the secretory phase, appears associated with increased bacterial proliferation. + + ++/+ represent the relative
abundance amount of microorganisms.
of bacteria through either oral or gut route, migration of bacteria
through the cervix, and retrograde spread through fallopian
tubes, another possible transmission route that influences uterine
microbiota is the semen (24, 69). It is essentially composed
of the spermatozoa cells and seminal plasma, which contains
many components contributing to the immune tolerance at
foeto-maternal interface (74). Semen, despite being synthesized
in a tissue that is not typically colonized by a microbiota,
is very far from being sterile; even in normal individuals,
usually the microbial count is 103 organisms/mL semen
(75). Weng et al. showed that the most abundant genera
present in seminal fluid are Lactobacillus (19.9%), Pseudomonas
(9.85%), Prevotella (8.51%), and Gardnerella (4.21%) (Figure 2).
Unsupervised clustering analysis revealed that the seminal
bacterial communities were clustered into three main groups:
Lactobacillus, Pseudomonas, and Prevotella predominant group
(76). For this reason, the seminal fluid is a microorganism source
for female genital tract. Indeed, it has been shown that bacteria
are shared among partners influencing the species composition
of each other’s reproductive tract microbiota (24). Semen, being
slightly basic and enriched with carbohydrates, represents an
ideal habitat for microorganisms so that it may function as a
perfect medium for the transmission of microorganisms, which
finally may reach the uterus and become resident.
PERSPECTIVES
Mucosal barriers are the first line of immune defense against
the external environment and one major benefit resulting
from the homeostatic relationship between the host with the
commensal microbiota is the resistance to pathogen colonization
(4). Although the uterinemicroenvironment has been considered
a sterile compartment in the past, it is now clear that some
commensal bacteria are present in the uterus. Therefore, it
is possible to hypothesize a cross-regulation of the uterine
microbiota and the local immune system. The uterine microbiota
and the uterine immune system have to adapt to the functional
changes of the uterus: first of all, they have to adapt to the cyclic
hormonal stimulation during the menstrual cycle implantation
and pregnancy. The uterine microbiota and the uterine immune
cells must together tolerate the paternal antigens in response to
the immunological stimulation by the semen, the embryo and
the fetus.
We have provided an overview of the immunological order in
an healthy endometrium since the recognition of the changes in
the local microbial communities may point toward reproductive
failure at different levels (from implantation failure in the uterus
to the pregnancy complications), as well as other gynecological
diseases (10, 11, 77). Furthermore, alteration of the uterine
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microbiota can also be a potential trigger for tumorigenesis.
It is well-known that the etiology and progression of cancer
may be influenced by microbial infections, as is Helicobacter
pylori for gastric cancer, and Fusobacteria and Porphyromonas
for colorectal cancer. It has been suggested that the presence of
Atopobium vaginae and Porphyromonas sp. in the gynecologic
tract is statistically associated with endometrial cancer (78).
It is an emerging notion that the microbiota is able to
influence the function of the host immune system, which keeps
a symbiotic relationship with the microbiota. Normally in other
mucosa, such as the intestinal mucosa, bacteria are confined
to the luminal side of the epithelial mucosa but occasionally
they breach the physical barrier. These commensal microbes
that penetrate the lamina propria are phagocytosed by resident
macrophages and engulfed and carried by DCs to the local
lymphoid aggregates and consequently modulate the adaptive
immune system (79). The nature of interplay between uterine
microbiota and the immune cells is not known. One can only
speculate that a similar mechanism may work in the case of
uterine compartment involving local lymphoid aggregates. The
symbiotic relationship between the uterine microbiota and the
innate and adaptive immune system probably has a fundamental
role in maintaining a balanced inflammatory milieu since this
mild bacterial stimulation could induce a potentially favorable
microenvironment for embryo implantation. On the other hand,
regulated stimulation of the immune system by microbiota
could facilitate induction of tolerance to the non-sterile semen
traversing through the uterine cavity.
In conclusion, we have discussed the potential role of
microbiota in the control of uterine cells present in the
microenvironment. We deliberately avoided reviewing and
summarizing the literature on the uterine microbiome in animal
models because our aim was to focus on human milieu. This can
be a limitation since important information on local mechanisms
can be obtained only using animal models. For example, it is
possible to compare the reproductive performances of germ free
and conventional animals and to study the rates of “immune
abortion” in germ free or in various conventional breeding
conditions. Animal models could also be used for analyzing the
potential synergistic effect of different immunological trigger in
the presence of bacterial products: this point has been indicated
as “ecology of danger” as suggested by DA Clark (80). These
studies are however not feasible to carry out in human subjects.
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